multiclonality of er expression in dcis: implications & future research | oncotarget
Published 1 year ago • 136 plays • Length 1:19Download video MP4
Download video MP3
Similar videos
-
1:35
her2 expression should be routinely evaluated in dcis to avoid under or overtreatment | oncoscience
-
5:39
ductal carcinoma in situ: anastrozole versus tamoxifen
-
0:51
what is dcis? #dcis #breastcancer #cancerawareness
-
0:34
unanswered questions in dcis progression
-
1:31
prognostic value of the dcis score in breast cancer
-
26:57
dcis - a pathologist's perspective | 2023 ductal carcinoma in situ patient forum
-
7:27
ductal carcinoma in situ (dcis) treatment options
-
11:31
prognostic and predictive value of her2 expression in ductal carcinoma in situ
-
1:17
future advances in dcis: de-escalation of hormonal therapy
-
6:07
what is ductal carcinoma in situ (dcis)?
-
4:03
what treatment should women with dcis think about?
-
0:34
understanding invasive and non-invasive breast cancer: what you need to know
-
0:15
ductal carcinoma in situ of breast - pathology #shorts
-
26:25
treatment decision making for dcis - dr. monica morrow
-
7:56
hormonal treatments produce similar quality of life outcomes in dcis
-
0:57
predictive biomarkers of recurrence may not be useful for de-escalating treatment in dcis
-
1:46:24
48- dcis
-
2:28
important biomarkers in luminal type breast cancer and dcis
-
0:30
stages of breast cancer